Financials

  • Market Capitalization 20.48 M
  • Employee 29
  • Founded 1986
  • CEO Carl Spana
  • Website www.palatin.com
  • Headquarter New Jersey, United States
  • FIGI BBG000BN9PY4
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
4.79
Rapporto prezzo/fatturato
1.91

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4539
LEXX
Lexaria Bioscience Corp. - Common Stock
12.48 USD+11.93%+6.67%+111.53%+1302.25%20.62 M USD
4543
NEUP
Neuphoria Therapeutics Inc. - Common Stock
3.79 USD+0.80%-1.81%-1.81%-68.42%20.48 M USD
4545
KZIA
Kazia Therapeutics Limited - American Depositary Shares
12.63 USD-8.28%-8.41%-1.33%+115.90%20.45 M USD
4548
ENLV
Enlivex Ltd. - Ordinary Shares
1.28 USD0.00%-15.79%-40.19%+19.63%20.26 M USD

Notizie